_id
6911c86cccc777a4e85d6664
Ticker
HUMDF
Name
Hua Medicine (Shanghai) Ltd
Exchange
PINK
Address
Hua Medicine, Building 2, Lane 36, Shanghai, China, 201203
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.huamedicine.com
Description
Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. It also provides Dorzagliatin in combination with GLP1RA for T2D and obesity; in combination with insulin to treat Type 1 Diabetes; second generation glucokinase (GK) inhibitor for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and GK NAM for metabolic disease. Hua Medicine (Shanghai) Ltd. was incorporated in 2011 and is based in Shanghai, China.
Last Close
0.4107
Volume
-
Current Price
0.4107
Change
0
Last Updated
2026-01-04T14:47:48.740Z
Image
-
Ipo Date
-
Market Cap
405356608
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
217432000
Cost Of Revenue
99613000
Gross Profit
117819000
Operating Expenses
183096000
Operating Income
-65277000
Interest Expense
-
Pretax Income
1183946000
Net Income
1183946000
Eps
1.1932739164737145
Dividends Per Share
-
Shares Outstanding
986989557
Income Tax Expense
-
EBITDA
-58005000
Operating Margin
-30.02179991905515
Total Other Income Expense Net
1249223000
Cash
1022788000
Short Term Investments
-
Receivables
80046000
Inventories
126331000
Total Current Assets
1242075000
Property Plant Equipment
118131000
Total Assets
1420001000
Payables
46889000
Short Term Debt
69718000
Long Term Debt
165861000
Total Liabilities
360822000
Equity
1059179000
Bs_currency_symbol
CNY
Depreciation
17021000
Change In Working Capital
-
Cash From Operations
-84414000
Capital Expenditures
0
Cash From Investing
1259000
Cash From Financing
-32633000
Net Change In Cash
-
Cf_currency_symbol
-
PE
2.738
PB
0.38472205892932165
ROE
111.77959532807958
ROA
83.3764201574506
FCF
-84414000
Fcf Percent
-0.38823172302145037
Piotroski FScore
2
Health Score
73
Deep Value Investing Score
9.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
9
Garp Investing Score
8.5
Growth Investing Score
7
Momentum Investing Score
3
Net Net Investing Score
6.5
Quality Investing Score
7
Value Investing Score
10
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
217432000
Quarters > 0 > income Statement > cost Of Revenue
99613000
Quarters > 0 > income Statement > gross Profit
117819000
Quarters > 0 > income Statement > operating Expenses
183096000
Quarters > 0 > income Statement > operating Income
-65277000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
1183946000
Quarters > 0 > income Statement > net Income
1183946000
Quarters > 0 > income Statement > eps
1.1932739164737145
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
992182921
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-58005000
Quarters > 0 > income Statement > operating Margin
-30.02179991905515
Quarters > 0 > income Statement > total Other Income Expense Net
1249223000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1022788000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
80046000
Quarters > 0 > balance Sheet > inventories
126331000
Quarters > 0 > balance Sheet > total Current Assets
1242075000
Quarters > 0 > balance Sheet > property Plant Equipment
118131000
Quarters > 0 > balance Sheet > total Assets
1420001000
Quarters > 0 > balance Sheet > payables
46889000
Quarters > 0 > balance Sheet > short Term Debt
69718000
Quarters > 0 > balance Sheet > long Term Debt
165861000
Quarters > 0 > balance Sheet > total Liabilities
360822000
Quarters > 0 > balance Sheet > equity
1059179000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
1183946000
Quarters > 0 > cash Flow > depreciation
17021000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-84414000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
1259000
Quarters > 0 > cash Flow > cash From Financing
-32633000
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.1932739164737145
Quarters > 0 > ratios > PB
0.38472205892932165
Quarters > 0 > ratios > ROE
111.77959532807958
Quarters > 0 > ratios > ROA
83.3764201574506
Quarters > 0 > ratios > FCF
-84414000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.38823172302145037
Quarters > 0 > health Score
73
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
108716000
Quarters > 1 > income Statement > cost Of Revenue
49806500
Quarters > 1 > income Statement > gross Profit
58909500
Quarters > 1 > income Statement > operating Expenses
91548000
Quarters > 1 > income Statement > operating Income
-32638500
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
591973000
Quarters > 1 > income Statement > net Income
591973000
Quarters > 1 > income Statement > eps
0.5966369582368573
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
992182921
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-29002500
Quarters > 1 > income Statement > operating Margin
-30.02179991905515
Quarters > 1 > income Statement > total Other Income Expense Net
624611500
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1022788000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
80046000
Quarters > 1 > balance Sheet > inventories
126331000
Quarters > 1 > balance Sheet > total Current Assets
1242075000
Quarters > 1 > balance Sheet > property Plant Equipment
118131000
Quarters > 1 > balance Sheet > total Assets
1420001000
Quarters > 1 > balance Sheet > payables
46889000
Quarters > 1 > balance Sheet > short Term Debt
69718000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
360822000
Quarters > 1 > balance Sheet > equity
1059179000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
591973000
Quarters > 1 > cash Flow > depreciation
8510500
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-42207000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
629500
Quarters > 1 > cash Flow > cash From Financing
-16316500
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.5966369582368573
Quarters > 1 > ratios > PB
0.38472205892932165
Quarters > 1 > ratios > ROE
55.88979766403979
Quarters > 1 > ratios > ROA
41.6882100787253
Quarters > 1 > ratios > FCF
-42207000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.38823172302145037
Quarters > 1 > health Score
73
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
153229000
Quarters > 2 > income Statement > cost Of Revenue
76267000
Quarters > 2 > income Statement > gross Profit
76962000
Quarters > 2 > income Statement > operating Expenses
243036000
Quarters > 2 > income Statement > operating Income
-166074000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-107903000
Quarters > 2 > income Statement > net Income
-107903000
Quarters > 2 > income Statement > eps
-0.1098655328473354
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
982136956
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-159286000
Quarters > 2 > income Statement > operating Margin
-108.38287791475506
Quarters > 2 > income Statement > total Other Income Expense Net
58171000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1139753000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
38973000
Quarters > 2 > balance Sheet > inventories
126672000
Quarters > 2 > balance Sheet > total Current Assets
1336496000
Quarters > 2 > balance Sheet > property Plant Equipment
129661000
Quarters > 2 > balance Sheet > total Assets
1527292000
Quarters > 2 > balance Sheet > payables
63722000
Quarters > 2 > balance Sheet > short Term Debt
115537000
Quarters > 2 > balance Sheet > long Term Debt
138736000
Quarters > 2 > balance Sheet > total Liabilities
1662758000
Quarters > 2 > balance Sheet > equity
-135466000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
-107903000
Quarters > 2 > cash Flow > depreciation
17189998
Quarters > 2 > cash Flow > change In Working Capital
-45067000
Quarters > 2 > cash Flow > cash From Operations
-191192000
Quarters > 2 > cash Flow > capital Expenditures
1868000
Quarters > 2 > cash Flow > cash From Investing
5675000
Quarters > 2 > cash Flow > cash From Financing
-15407000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.1098655328473354
Quarters > 2 > ratios > PB
-2.9776006365375816
Quarters > 2 > ratios > ROE
79.65319711219051
Quarters > 2 > ratios > ROA
-7.06498822752951
Quarters > 2 > ratios > FCF
-193060000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.2599442664247629
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
76614500
Quarters > 3 > income Statement > cost Of Revenue
38133500
Quarters > 3 > income Statement > gross Profit
38481000
Quarters > 3 > income Statement > operating Expenses
121518000
Quarters > 3 > income Statement > operating Income
-83037000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-53951500
Quarters > 3 > income Statement > net Income
-53951500
Quarters > 3 > income Statement > eps
-0.0549327664236677
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
982136956
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-79643000
Quarters > 3 > income Statement > operating Margin
-108.38287791475506
Quarters > 3 > income Statement > total Other Income Expense Net
29085500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1139753000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
34388000
Quarters > 3 > balance Sheet > inventories
126698000
Quarters > 3 > balance Sheet > total Current Assets
1336496000
Quarters > 3 > balance Sheet > property Plant Equipment
129661000
Quarters > 3 > balance Sheet > total Assets
1527292000
Quarters > 3 > balance Sheet > payables
63722000
Quarters > 3 > balance Sheet > short Term Debt
115537000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1662758000
Quarters > 3 > balance Sheet > equity
-135466000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-53951500
Quarters > 3 > cash Flow > depreciation
8594999
Quarters > 3 > cash Flow > change In Working Capital
-22533500
Quarters > 3 > cash Flow > cash From Operations
-95596000
Quarters > 3 > cash Flow > capital Expenditures
934000
Quarters > 3 > cash Flow > cash From Investing
2837500
Quarters > 3 > cash Flow > cash From Financing
-7703500
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0549327664236677
Quarters > 3 > ratios > PB
-2.9776006365375816
Quarters > 3 > ratios > ROE
39.826598556095256
Quarters > 3 > ratios > ROA
-3.532494113764755
Quarters > 3 > ratios > FCF
-96530000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.2599442664247629
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
255892000
Annuals > 0 > income Statement > cost Of Revenue
131168000
Annuals > 0 > income Statement > gross Profit
124724000
Annuals > 0 > income Statement > operating Expenses
477368000
Annuals > 0 > income Statement > operating Income
-352644000
Annuals > 0 > income Statement > interest Expense
8609000
Annuals > 0 > income Statement > pretax Income
-250144000
Annuals > 0 > income Statement > net Income
-250144000
Annuals > 0 > income Statement > eps
-0.25488688520200947
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
981392196
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-206952000
Annuals > 0 > income Statement > operating Margin
-137.80970096759572
Annuals > 0 > income Statement > total Other Income Expense Net
102500000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
1139753000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
38973000
Annuals > 0 > balance Sheet > inventories
126672000
Annuals > 0 > balance Sheet > total Current Assets
1336496000
Annuals > 0 > balance Sheet > property Plant Equipment
129661000
Annuals > 0 > balance Sheet > total Assets
1527292000
Annuals > 0 > balance Sheet > payables
63722000
Annuals > 0 > balance Sheet > short Term Debt
115537000
Annuals > 0 > balance Sheet > long Term Debt
138736000
Annuals > 0 > balance Sheet > total Liabilities
1662758000
Annuals > 0 > balance Sheet > equity
-135466000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-250144000
Annuals > 0 > cash Flow > depreciation
34583000
Annuals > 0 > cash Flow > change In Working Capital
-107992000
Annuals > 0 > cash Flow > cash From Operations
-417966000
Annuals > 0 > cash Flow > capital Expenditures
3860000
Annuals > 0 > cash Flow > cash From Investing
10043000
Annuals > 0 > cash Flow > cash From Financing
83718000
Annuals > 0 > cash Flow > net Change In Cash
-321071000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-0.25488688520200947
Annuals > 0 > ratios > PB
-2.975342705159967
Annuals > 0 > ratios > ROE
184.6544520396262
Annuals > 0 > ratios > ROA
-16.3782695123133
Annuals > 0 > ratios > FCF
-421826000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.6484532537164116
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
76610000
Annuals > 1 > income Statement > cost Of Revenue
39236000
Annuals > 1 > income Statement > gross Profit
37374000
Annuals > 1 > income Statement > operating Expenses
326466000
Annuals > 1 > income Statement > operating Income
-289092000
Annuals > 1 > income Statement > interest Expense
7907000
Annuals > 1 > income Statement > pretax Income
-211234000
Annuals > 1 > income Statement > net Income
-211234000
Annuals > 1 > income Statement > eps
-0.2161946099719929
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
977054886
Annuals > 1 > income Statement > income Tax Expense
134739000
Annuals > 1 > income Statement > EBITDA
-167089000
Annuals > 1 > income Statement > operating Margin
-377.3554366270722
Annuals > 1 > income Statement > total Other Income Expense Net
77858000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
1460824000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
979000
Annuals > 1 > balance Sheet > inventories
67865000
Annuals > 1 > balance Sheet > total Current Assets
1572477000
Annuals > 1 > balance Sheet > property Plant Equipment
114538000
Annuals > 1 > balance Sheet > total Assets
1725373000
Annuals > 1 > balance Sheet > payables
51633000
Annuals > 1 > balance Sheet > short Term Debt
41471000
Annuals > 1 > balance Sheet > long Term Debt
106844000
Annuals > 1 > balance Sheet > total Liabilities
1624222000
Annuals > 1 > balance Sheet > equity
101151000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-211234000
Annuals > 1 > cash Flow > depreciation
36238000
Annuals > 1 > cash Flow > change In Working Capital
1130991000
Annuals > 1 > cash Flow > cash From Operations
889367000
Annuals > 1 > cash Flow > capital Expenditures
9842000
Annuals > 1 > cash Flow > cash From Investing
8077000
Annuals > 1 > cash Flow > cash From Financing
69068000
Annuals > 1 > cash Flow > net Change In Cash
970192000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-0.2161946099719929
Annuals > 1 > ratios > PB
3.9671030605747846
Annuals > 1 > ratios > ROE
-208.83036252731065
Annuals > 1 > ratios > ROA
-12.242801991221608
Annuals > 1 > ratios > FCF
879525000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
11.480550841926641
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
17599000
Annuals > 2 > income Statement > cost Of Revenue
9910000
Annuals > 2 > income Statement > gross Profit
7689000
Annuals > 2 > income Statement > operating Expenses
274806999
Annuals > 2 > income Statement > operating Income
-267117999
Annuals > 2 > income Statement > interest Expense
3667000
Annuals > 2 > income Statement > pretax Income
-203507000
Annuals > 2 > income Statement > net Income
-203766000
Annuals > 2 > income Statement > eps
-0.21077856033588424
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
966730201
Annuals > 2 > income Statement > income Tax Expense
259000
Annuals > 2 > income Statement > EBITDA
-168063000
Annuals > 2 > income Statement > operating Margin
-1517.8021421671685
Annuals > 2 > income Statement > total Other Income Expense Net
63610999
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
490632000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
12943000
Annuals > 2 > balance Sheet > inventories
1915000
Annuals > 2 > balance Sheet > total Current Assets
940257000
Annuals > 2 > balance Sheet > property Plant Equipment
139708000
Annuals > 2 > balance Sheet > total Assets
1121497000
Annuals > 2 > balance Sheet > payables
20982000
Annuals > 2 > balance Sheet > short Term Debt
55413000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
841917000
Annuals > 2 > balance Sheet > equity
279580000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
-203507000
Annuals > 2 > cash Flow > depreciation
31777000
Annuals > 2 > cash Flow > change In Working Capital
-27132000
Annuals > 2 > cash Flow > cash From Operations
-230114000
Annuals > 2 > cash Flow > capital Expenditures
27467000
Annuals > 2 > cash Flow > cash From Investing
-4752000
Annuals > 2 > cash Flow > cash From Financing
21476000
Annuals > 2 > cash Flow > net Change In Cash
-184606000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
-0.21077856033588424
Annuals > 2 > ratios > PB
1.4201162227294513
Annuals > 2 > ratios > ROE
-72.88289577222977
Annuals > 2 > ratios > ROA
-18.169107897747384
Annuals > 2 > ratios > FCF
-257581000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-14.636115688391385
Annuals > 2 > health Score
17
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
321670000
Annuals > 3 > income Statement > operating Income
-320517000
Annuals > 3 > income Statement > interest Expense
3950000
Annuals > 3 > income Statement > pretax Income
-325734000
Annuals > 3 > income Statement > net Income
-330951000
Annuals > 3 > income Statement > eps
-0.3456448676183165
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
957488541
Annuals > 3 > income Statement > income Tax Expense
5217000
Annuals > 3 > income Statement > EBITDA
-309686000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-4064000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
675238000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
9701000
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
704600000
Annuals > 3 > balance Sheet > property Plant Equipment
156600000
Annuals > 3 > balance Sheet > total Assets
903553000
Annuals > 3 > balance Sheet > payables
23785000
Annuals > 3 > balance Sheet > short Term Debt
13296000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
453222000
Annuals > 3 > balance Sheet > equity
450331000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-325734000
Annuals > 3 > cash Flow > depreciation
31589000
Annuals > 3 > cash Flow > change In Working Capital
-19168000
Annuals > 3 > cash Flow > cash From Operations
-272981000
Annuals > 3 > cash Flow > capital Expenditures
66891000
Annuals > 3 > cash Flow > cash From Investing
-68219000
Annuals > 3 > cash Flow > cash From Financing
-6134000
Annuals > 3 > cash Flow > net Change In Cash
-356852000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.3456448676183165
Annuals > 3 > ratios > PB
0.8732255691673458
Annuals > 3 > ratios > ROE
-73.49061024002344
Annuals > 3 > ratios > ROA
-36.62773517436166
Annuals > 3 > ratios > FCF
-339872000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
23
Valuation > metrics > PE
2.738
Valuation > metrics > PB
0.38472205892932165
Valuation > final Score
90
Valuation > verdict
67.1% Undervalued
Profitability > metrics > ROE
111.77959532807958
Profitability > metrics > ROA
95.32000885614798
Profitability > metrics > Net Margin
5.445132271238824
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.34066196554123523
Risk > metrics > Interest Coverage
-0.0525600446394423
Risk > final Score
60
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.651804780158995
Liquidity > metrics > Quick Ratio
9.568413560077868
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
100
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
60
Prev Risks > 1
17
Prev Risks > 2
17
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:59:47.753Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
CNY
Earnings History > 1 > eps Actual
-0.0134
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0134
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
CNY
Earnings History > 2 > eps Actual
-0.0132
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0132
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CNY
Earnings History > 3 > eps Actual
-0.0177
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0177
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CNY
Earnings History > 4 > eps Actual
-0.017
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.017
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
-0.0129
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0129
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
-0.0129
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0129
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
-0.0144
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0144
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
-0.0141
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0141
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
-0.0183
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0183
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
-0.0187
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0187
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
-0.252
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.252
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
-0.2524
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.2524
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
-1.6031
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-1.6031
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
-0.4647
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.4647
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
-0.0346
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0346
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
-0.0338
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0338
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
-0.1025
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.1025
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
-0.226
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.226
Earnings History > 18 > surprise Percent
-
Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. It also provides Dorzagliatin in combination with GLP1RA for T2D and obesity; in combination with insulin to treat Type 1 Diabetes; second generation glucokinase (GK) inhibitor for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and GK NAM for metabolic disease. Hua Medicine (Shanghai) Ltd. was incorporated in 2011 and is based in Shanghai, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Hua Medicine (Shanghai) Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0134
EPS Estimate
0
EPS Difference
-0.0134
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.